Treating the untreatable cancers

It’s a secret oncologists rarely share with their patients: around 25 percent of all cancers are untreatable, and the prognosis is worse for colon (colorectal) and lung cancers, with half of cases immune to chemotherapy.

But the untreatable may soon be very treatable with a new therapy that blends two approaches that have always been relegated to the fringes of medicine: fasting and high-dose vitamin C, given intravenously. Both have had hit-and-miss research results when used independently, but combining the two seems to have a super-charging effect that kills these hard-to-treat cancer cells without affecting the surrounding healthy cells.

The therapy is still in its early stages. It’s been tested on lines of colorectal cancer